Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review
AUTOR(ES)
Gunnell, David
FONTE
BMJ Publishing Group Ltd.
RESUMO
Objective To investigate whether selective serotonin reuptake inhibitor (SSRI) antidepressants are associated with an increased risk of suicide related outcomes in adults.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=549105Documentos Relacionados
- Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery
- Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials
- Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials
- Selective serotonin reuptake inhibitors (SSRIs) and depression after myocardial infarction (MI)
- Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials
